Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B

Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Bürgisser, Philippe; Rauch, Andri; Hirschel, Bernard; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L; Bernasconi, Enos; Held, Leonhard; Günthard, Huldrych F; Swiss HIV Cohort, Study (2011). Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. Clinical infectious diseases, 53(11), pp. 1143-52. Cary, N.C.: Oxford University Press 10.1093/cid/cir669

[img]
Preview
Text
cir669.pdf - Published Version
Available under License Publisher holds Copyright.

Download (179kB) | Preview

Antiretroviral compounds have been predominantly studied in human immunodeficiency virus type 1 (HIV-1) subtype B, but only ~10% of infections worldwide are caused by this subtype. The analysis of the impact of different HIV subtypes on treatment outcome is important.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Rauch, Andri

ISSN:

1058-4838

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:24

Last Modified:

05 Dec 2022 14:06

Publisher DOI:

10.1093/cid/cir669

PubMed ID:

21998284

Web of Science ID:

000297279900020

BORIS DOI:

10.7892/boris.8265

URI:

https://boris.unibe.ch/id/eprint/8265 (FactScience: 213781)

Actions (login required)

Edit item Edit item
Provide Feedback